2005
DOI: 10.1016/j.yexcr.2005.01.004
|View full text |Cite|
|
Sign up to set email alerts
|

Responses of keratinocytes to substrate-bound vitronectin:growth factor complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
26
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(27 citation statements)
references
References 50 publications
0
26
0
1
Order By: Relevance
“…There is also potential to combine established wound healing therapies with the nanoporous membrane to provide a superior topographical and physicochemical approach to wound healing. For example, substrate-bound vitronectin (VN): growth factor complexes have been shown to stimulate keratinocyte proliferation and migration 54,55 and increase reepithelialization of DDPT burn injuries in vivo. 20 Taken together, keratinocyte function may be further stimulated to drive repair by a membrane functionalized with the complexes.…”
Section: Further Applicationmentioning
confidence: 99%
“…There is also potential to combine established wound healing therapies with the nanoporous membrane to provide a superior topographical and physicochemical approach to wound healing. For example, substrate-bound vitronectin (VN): growth factor complexes have been shown to stimulate keratinocyte proliferation and migration 54,55 and increase reepithelialization of DDPT burn injuries in vivo. 20 Taken together, keratinocyte function may be further stimulated to drive repair by a membrane functionalized with the complexes.…”
Section: Further Applicationmentioning
confidence: 99%
“…For example, TSP-1 induces focal adhesion dissociation through calreticulin and phosphatidylinositol 3-kinase signaling (Goicoechea et al, 2000;Orr et al, 2002). Blockade of integrin interactions with ECM ligands has been reported previously (Hadari et al, 2000;Hughes, 2001;Wu et al, 2007) as well as indirect effects on adhesion through modulation of growth factor signaling (Bornstein and Sage, 2002;Hollier et al, 2005Hollier et al, , 2008. Finally, the FN-binding properties of tenascin-C reduce cell adhesion and modify intracellular signaling by preventing syndecan-4 receptor binding to the C-terminal heparin-binding (HepII) domain of FN (Huang et al, 2001;Orend et al, 2003;Midwood et al, 2004a).…”
Section: Introductionmentioning
confidence: 67%
“…12 This new technology is based on the finding that a synergistic effect occurs between GFs and a specific ECM protein called vitronectin (VN). [13][14][15][16] This has led to the development of novel dimeric, trimeric, and multimeric growth-promoting complexes incorporating GFs, such as insulin-like growth factors (IGFs) and insulin-like growth factor binding proteins (IGFBPs), in conjunction with VN (VN:GF). Further, the addition of these complexes to defined media has been demonstrated to stimulate short-term migration and proliferation in a range of cells, including adult skin-and corneal-derived epithelial cells.…”
Section: Introductionmentioning
confidence: 99%
“…Further, the addition of these complexes to defined media has been demonstrated to stimulate short-term migration and proliferation in a range of cells, including adult skin-and corneal-derived epithelial cells. 13,16 In addition, this technology has proved successful in removing serum from the serial expansion of Kc; however, there is a need for a feeder cell layer in the culture system. Moreover, the approach reported by Dawson et al still used serum in the initial isolation step and involved binding the ECM:GF complex to the culture dishes.…”
Section: Introductionmentioning
confidence: 99%